Acute COPD exacerbations
JA Wedzicha, R Singh… - Clinics in chest …, 2014 - chestmed.theclinics.com
The natural course of COPD is interrupted by episodes of respiratory symptom worsening,
termed exacerbations. 1 COPD exacerbations are important events in COPD and are major …
termed exacerbations. 1 COPD exacerbations are important events in COPD and are major …
Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study
Background COPD can be diagnosed early using spirometry, but spirometry use is only
recommended in symptomatic smokers, even though early stages of COPD can be …
recommended in symptomatic smokers, even though early stages of COPD can be …
How long does a COPD exacerbation last?–Predictors for duration more than 3 weeks
G Husebø, P Bakke, M Aanerud… - European …, 2014 - Eur Respiratory Soc
Background: There is a large diversity in both duration and severity of acute exacerbations
of COPD (AECOPD). This study aimed to identify predictors for AECOPD lasting more than 3 …
of COPD (AECOPD). This study aimed to identify predictors for AECOPD lasting more than 3 …
Prediction and prevention of exacerbations and mortality in patients with COPD
K Kostikas, A Clemens, F Patalano - Expert Review of Respiratory …, 2016 - Taylor & Francis
Introduction: Exacerbations of chronic obstructive pulmonary disease (COPD) are important
events in the natural history of the disease that have significant impact on important …
events in the natural history of the disease that have significant impact on important …
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts
Since the publication of the new Global Initiative for Chronic Obstructive Lung Disease
(GOLD) proposal for the assessment of chronic obstructive lung disease (COPD), four …
(GOLD) proposal for the assessment of chronic obstructive lung disease (COPD), four …
[HTML][HTML] Long-term outcomes following first short-term clinically important deterioration in COPD
IP Naya, L Tombs, H Muellerova, C Compton… - Respiratory …, 2018 - Springer
Background Chronic obstructive pulmonary disease (COPD) is characterized by varying
trajectories of decline. Information regarding the prognostic value of preventing short-term …
trajectories of decline. Information regarding the prognostic value of preventing short-term …
[HTML][HTML] Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013
OA Oshagbemi, SJ Keene, JHM Driessen, R Jordan… - Respiratory …, 2018 - Elsevier
Introduction Exacerbations of chronic obstructive pulmonary disease are characterised by
increased symptoms such as dyspnoea, cough and sputum production and/or purulence …
increased symptoms such as dyspnoea, cough and sputum production and/or purulence …
COPD: it is time to change!
C Tantucci, L Pini - International Journal of Chronic Obstructive …, 2015 - Taylor & Francis
COPD is a common cause of disability, morbidity and mortality worldwide and a major global
health problem with enormous direct and indirect health care costs. Different reasons can be …
health problem with enormous direct and indirect health care costs. Different reasons can be …
[HTML][HTML] ICE COLD ERIC–International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts–study protocol for an international …
L Siebeling, G ter Riet, WM Van der Wal… - BMC pulmonary …, 2009 - Springer
Abstract Background Chronic Obstructive Pulmonary Disease (COPD) is a systemic disease;
morbidity and mortality due to COPD are on the increase, and it has great impact on patients' …
morbidity and mortality due to COPD are on the increase, and it has great impact on patients' …
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials
K Wing, E Williamson, JR Carpenter… - European …, 2021 - Eur Respiratory Soc
Real-world data provide the potential for generating evidence on drug treatment effects in
groups excluded from trials, but rigorous, validated methodology for doing so is lacking. We …
groups excluded from trials, but rigorous, validated methodology for doing so is lacking. We …